The 2nd Annual Meeting of the Japan Disease Stem Cell Society【Osaka Prefecture】

科学・医療分野の学会で、研究者がスクリーンを使って研究成果を発表し、参加者が聴講する様子
             

Event Details

  • Date: –

Disease Stem Cells / iPS Cells & Organoids / Osaka

The 2nd Annual Meeting of the Japan Disease Stem Cell Society [Osaka Prefecture]

The 2nd Annual Meeting of the Japan Disease Stem Cell Society will take place in Osaka, Japan, on February 12–13, 2027, as an in-person conference. Under the theme “Advancing Disease Stem Cell Science through Dialogue, Integration, and Co-Creation,” the meeting brings together basic and clinical researchers and industry participants to discuss disease stem cell science, including iPS cell research, organoids, and genome editing.

Date
February 12 (Fri)–13 (Sat), 2027
Venue
Congres Square GRAND GREEN OSAKA
Chair
Haruhisa Inoue
Theme
Advancing Disease Stem Cell Science through Dialogue, Integration, and Co-Creation

Meeting Theme

Advancing Disease Stem Cell Science through Dialogue, Integration, and Co-Creation

Meeting Information

Meeting Organization

  • Chair: Haruhisa Inoue (Center for iPS Cell Research and Application [CiRA], Kyoto University)
  • Society Secretariat: Japan Disease Stem Cell Society (JDSCS), Center for iPS Cell Research and Application (CiRA), Kyoto University
  • Meeting Secretariat: Academic Brains Inc.
  • Contact: jdscs2027@academicbrains.jp

Call for Abstracts

  • Submission period: October 22–December 18, 2026
  • Scope: Disease stem cell research
  • Presentation format: General abstracts are planned as posters
  • Young Investigator Award: Selected poster presenters may be invited to an oral presentation session. The first author must be aged 45 or younger as of February 13, 2027, and must opt in to oral-presentation consideration.
  • Submission language: Japanese is standard, but English abstracts are also accepted
  • Submission limits: Up to 10 authors (including the presenter) and 10 affiliations. The Japanese abstract body is limited to 600 full-width characters; see the official instructions for English submissions.
  • Acceptance notification: Expected in mid-January 2027

English-language abstracts must be prepared using the official English Abstract Submission Form (XLSX) and emailed to jdscs2027@academicbrains.jp. Participation registration is separate and takes place through the Japanese-language registration page. See official abstract instructions (Japanese, with English submission guidance).

Registration and Fees

  • Early registration: October 22–December 18, 2026 (until 24:00 Japan time)
  • Late registration: December 19, 2026–February 13, 2027 (the official registration cutoff is stated as the end of the meeting program)
  • Registration and payment: Online only, including on-site participants; cash and credit-card payments at the venue are not accepted
  • Name badge: Download and print it before the meeting and bring it to the venue
  • Cancellation policy: No refunds after payment
Category Early registration Late registration
Regular member (non-taxable) JPY 10,000 JPY 12,000
Student member (non-taxable) JPY 3,000 JPY 5,000
Non-member (tax included) JPY 20,000 JPY 22,000

Registration is online only. Please review the official registration page (Japanese) for terms and instructions. The organizer does not issue Japanese qualified invoices.

Related Research Areas

  • Disease research using patient-derived iPS cells
  • Organoid-based disease models
  • Genome editing and single-cell analysis
  • Spatial transcriptomics
  • Artificial intelligence and computational approaches to disease stem cell research
  • Applications to disease mechanisms, drug discovery, precision medicine, and digital medicine

These topics are mentioned in the chair’s official greeting as related areas of disease stem cell science, not as a finalized list of program sessions.

Keynote Speakers and Program

  • February 12 (Fri), 2027 — scheduled: Masayo Takahashi, MD, PhD (President and CEO, Vision Care Inc. and VCCT Inc.)
  • February 13 (Sat), 2027 — scheduled: Akira Sawa, MD (Johns Hopkins Schizophrenia Center; Johns Hopkins University)
  • February 13 (Sat), 2027 — scheduled: Takanori Takebe (The University of Osaka; Institute of Science Tokyo; Cincinnati Children’s Hospital)

The speakers and planned dates have been announced. Lecture titles and a full timetable have not been published. Check the official program page (Japanese) for updates.

Information for Sponsors and Exhibitors

  • Co-sponsored scientific seminars and corporate exhibits
  • Program and abstract book advertisements, website banner advertisements, and on-screen advertisements at the venue
  • Name badge holders and lanyards; congress bags
  • Donations

See the official sponsorship and exhibition information (Japanese) for application materials and details.

Meeting Overview

The chair’s official greeting describes disease stem cell science as an emerging field that uses stem cells, including patient-derived cells, to study disease mechanisms and translate discoveries into healthcare and society. The meeting emphasizes dialogue across basic and clinical research, life and information sciences, academia, and industry.

Venue Access

  • JR: Approximately 5 minutes on foot from the Umekita Underground Gate of Osaka Station (connected by an underground walkway)
  • Osaka Metro: Approximately 10 minutes on foot from the North Gate of Umeda Station on the Midosuji Line
  • Hankyu Railway: Approximately 12 minutes on foot from the 2F Central Gate of Osaka-umeda Station
  • Hanshin Railway: Approximately 8 minutes on foot from the West Exit of Osaka-umeda Station
  • Venue floor: 4F, Grand Green Osaka South Building

For maps and detailed directions, see the venue’s official English access information.